Design Therapeutics Inc (DSGN)
EBITDA Growth
-14.81%
TTM · Period ending:
DSGN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-14.81%period ending
Latest reported-14.81%period ending
DSGN TTM EBITDA YoY % (-327.27% → -14.81%)
Year-over-year change
High-resolution chart · PNG
DSGN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -14.8119% | |
| -24.2993% | |
| -41.1863% | |
| -41.6091% | |
| -25.8507% | |
| 4.3632% | |
| 26.1334% | |
| 34.304% | |
| 32.2861% | |
| 15.6234% | |
| -5.4418% | |
| -26.766% | |
| -46.5071% | |
| -59.909% | |
| -76.84% | |
| -99.2301% | |
| -157.7409% | |
| -221.9988% | |
| -327.2673% |